AZNVSCRBU• 12 Months (Normalized)
AZN vs CRBU (AstraZeneca PLC vs Caribou Biosciences Inc.)
Showing Closing Date Range from Sep, 11, 2025 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AZN Performance $160.17
-1.25%
AstraZeneca PLC
Normalized Baseline0.00%
CRBU Performance $1.27
-33.51%
Caribou Biosciences Inc.
Normalized Baseline0.00%
Alpha Spread Margin AZN LEADS
+32.26%
AZN outperforming by 32.26%
AZNCRBU
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AZN CRBU
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | AZN Price | AZN Gain (%) | CRBU Price | CRBU Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $160.17 | -1.25% | $1.27 | -33.51% | +32.26% |
| Sep 10, 2026 | $159.64 | -1.58% | $1.37 | -28.27% | +26.69% |
| Sep 09, 2026 | $156.94 | -3.24% | $1.44 | -24.61% | +21.37% |
| Sep 08, 2026 | $160.04 | -1.33% | $1.54 | -19.37% | +18.04% |
| Sep 04, 2026 | $162.70 | +0.31% | $1.57 | -17.80% | +18.11% |
| Sep 03, 2026 | $164.77 | +1.58% | $1.57 | -17.80% | +19.38% |
| Sep 02, 2026 | $161.63 | -0.35% | $1.60 | -16.23% | +15.88% |
| Sep 01, 2026 | $162.47 | +0.17% | $1.55 | -18.85% | +19.02% |
| Aug 31, 2026 | $162.13 | -0.04% | $1.54 | -19.37% | +19.33% |
| Aug 28, 2026 | $162.70 | +0.31% | $1.62 | -15.18% | +15.49% |
| Aug 27, 2026 | $164.52 | +1.43% | $1.66 | -13.09% | +14.52% |
| Aug 26, 2026 | $166.27 | +2.51% | $1.65 | -13.61% | +16.12% |
| Aug 25, 2026 | $169.66 | +4.60% | $1.76 | -7.85% | +12.45% |
| Aug 24, 2026 | $166.71 | +2.78% | $1.64 | -14.14% | +16.92% |
| Aug 21, 2026 | $165.98 | +2.33% | $1.66 | -13.09% | +15.42% |
Page 1 of 17